AXIM BIOTECHNOLOGIES, INC. (AXIM) Net margin 2015–2023
AXIM BIOTECHNOLOGIES, INC. (AXIM) net profit margin by fiscal year — reported net income divided by reported revenue.
-20395.0%FY2023 · since FY2015: -20539.2% → -20395.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -20395.0% | +16953.0 pp |
| FY2022 | -37348.0% | -10830.7 pp |
| FY2021 | -26517.2% | — |
| FY2019 | -806.5% | +2646.6 pp |
| FY2018 | -3453.0% | +5308.7 pp |
| FY2017 | -8761.7% | +3584.3 pp |
| FY2016 | -12346.0% | +8193.2 pp |
| FY2015 | -20539.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More AXIM financial trends
AXIM RevenueAXIM Net incomeAXIM Gross profitAXIM Gross marginAXIM Operating incomeAXIM Operating marginAXIM Operating cash flowAXIM Free cash flowAXIM Capital expendituresAXIM Return on equityAXIM Stock buybacksAXIM Dividends paidAXIM Total assetsAXIM Total liabilitiesAXIM Shareholders’ equityAXIM overview →